PeriodontitisNCT05876455
Comparative Evaluation of Minimally Invasive Nonsurgical Periodontal Therapy Versus Conventional Subgingival Instrumentation
A study testing Conventional Subgingival Instrumentation and minimally invasive non-surgical periodontal therapy in people with Periodontitis and Subgingival Plaque, run by Postgraduate Institute of Dental Sciences Rohtak at 1 site in India.
Trial summary
Background- The use of minimally invasive procedures has recently been advocated for the treatment of periodontitis, to minimize patient discomfort and maximize the healing potential. Read more about this study
- Who is it for?
- Ages 18 to 50 yearsHealthy volunteers can take part
- Conditions the study is for
- Periodontitis, Subgingival Plaque
- What is being tested?
- Conventional Subgingival Instrumentation and minimally invasive non-surgical periodontal therapy
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteIndia
- Study dates
- 10 Jul 2023to 10 Nov 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Systemically healthy patients having generalised Stage 2 or stage 3 periodontitis according to the American Academy of Periodontology (AAP) and the European Federation of Periodontology (EFP) periodontal classification
- A full-mouth plaque score (FMPS) and full-mouth bleeding score (FMBS) <20%, at least 5 teeth in each quadrant.
Who cannot join
- pregnant or lactating
- requiring antibiotic premedication
- received antibiotic treatment in the previous 3 months
- received a course of periodontal treatment within the past 6 months
- smokers
- signs of mobility and/or traumatic occlusion
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Comparative Evaluation of Minimally Invasive Nonsurgical Periodontal Therapy Versus Conventional Subgingival Instrumentation in Patients With Generalized Stage 2 and 3 Periodontitis - A Randomized Controlled Trial
Background- The use of minimally invasive procedures has recently been advocated for the treatment of periodontitis, to minimize patient discomfort and maximize the healing potential. These techniques usually involve the use of magnification lenses or microscopes and small instruments which reduce the risk of tissue trauma compared with traditional instruments.
Rationale- So far only descriptive data about the clinical effects of such procedure are available and comparative studies that would include other treatment alternatives are lacking. Therefore, the aim of this study is, on split-mouth model, to compare the number of diseased sites (defined by probing depth ˃ 4 mm and bleeding on probing) after conventional subgingival instrumentation and Minimally invasive nonsurgical periodontal therapy (MINST) with the usage of special mini instruments and magnifying loupes.
Read more
Objectives- To compare sites that have residual probing depth and require further surgical intervention after undergoing the two treatment modalities.
Methods- In this split mouth randomized controlled trial, Test group will undergo non surgical therapy under magnification and using special mini bladed instruments while the control group will undergo conventional subgingival instrumentation. Reevaluation will be at 6 weeks and 3 months.
Expected outcomes- If both the groups differ in outcomes after therapy, MINST can be used to minimize the number of sites that require surgery and hence will reduce treatment costs and morbidity.
Read the detailed description
Aim and objectives- The aim of this study is to evaluate the clinical outcomes after minimally invasive nonsurgical periodontal therapy versus after conventional scaling and root planing in stage 2 and stage 3 generalised periodontitis patients.
Primary Objective- 1. Comparative evaluation of number of sites with residual pocket depth > 4 mm and bleeding on pocket probing after MINST versus conventional SI at the end of 6 weeks and 3 months Secondary objective-
- Comparative evaluation of periodontal parameters viz. probing depth, clinical attachment level, gingival recession, treatment time and patient reported outcomes after MINST versus conventional SI at the end of 6 weeks and 3 months.
Methodology- Study design- This randomized controlled trial will be conducted in the department of Periodontics, Post graduate institute of dental sciences (PGIDS), Rohtak in accordance with the ethical standards outlined in the declaration of Helsinki 1975, as revised in 2013.The study design was approved by Institutional review board, PGIDS, Rohtak and ethical acceptance applied for from the Ethical committee of PGIDS, Rohtak. Patients coming to the out patient department of Periodontics, after examination, will be included in the study if they meet the following inclusion criteria.
Randomisation- It is a split mouth study so 2 quadrants within the same arch (intra arch) in each patient will be randomly allocated to test group and control group. For the randomization process, a computer-generated list will be used to define side and treatment modality.
Participants belonging to both the groups will receive oral hygiene instructions including toothbrushing, interdental cleaning, and plaque control reinforcement at every visit.
Test group- Experimental sites designated to receive minimally invasive non-surgical periodontal therapy will undergo careful scaling and root planing under magnification (use of 3.5 X magnification loupes) with mini curettes and using an ultrasonic device with specific thin and delicate tips. These instruments will be carefully inserted through the periodontal pocket of the affected tooth to reach the root surface for debridement. Caution will be taken to preserve the stability of soft tissues.
Control group- On the conventional non-surgical periodontal therapy side, a power-driven piezo-electric ultrasonic scaling device with scaling tips will be used the majority of the time to debride subgingival biofilm and calculus, and manual standard Gracey curette instruments (Gracey curettes Hu-Friedy, Chicago, IL, USA) will be used to remove residual deposits from the root surface.
Both procedures will be performed under local anesthesia and by a single experienced periodontist. All patients will be recalled after 6 weeks and 3 months after treatment for re-evaluation and professional supra-gingival plaque control.
Primary Outcome Measures:
Number of diseased sites [ Time Frame: 6 weeks, 3 months] Difference in No of Sites with PPD (probing pocket depth) > 4 mm and BOP (bleeding upon probing)
Secondary Outcome Measures:
PPD [ [ Time Frame: 6 weeks, 3 months] Average probing pocket depth CAL [ Time Frame: 6 weeks, 3 months] Clinical attachment level REC [ Time Frame: 6 weeks, 3 months] Gingival recession Sample size-: Sample size was calculated using G power statistical software. Using probing depth reduction as the outcome to determine effect size (as determined from a previous study- Ribeiro, F.V.; Casarin, R.C.; Palma, M.A.; Junior, F.H.; Sallum, E.A.; Casati, M.Z. Clinical and patient-centered outcomes after minimally invasive non-surgical or surgical approaches for the treatment of intrabony defects: A randomized clinical trial.J. Periodontol. 2011, 82, 1256-1266), a power of 80% and error of 5%, a sample size of 18 patients was calculated. Taking into account 10% attrition rate a total of 20 patients and a total of 40 quadrants will be recruited for this split mouth study.
Data collection and statistical analysis plan- Periodontal parameters will include plaque index, periodontal probing depth (PD): the distance from the free gingival margin to the bottom of gingival sulcus, gingival recession depth (REC), clinical attachment level (CAL), bleeding on pocket probing (BOP): recorded as bleeding site 30s after probing base of sulcus. These will be assessed at six sites per tooth at baseline, 6 weeks after treatment and 3 months after treatment.
The number of sites requiring surgical intervention will be noted at the last follow up at 3 months and compared between test and control groups. The time taken for both treatment types will also be noted.
The periodontal probe (UNC-15, Hu-Friedy, Chicago, IL, USA) will be used for periodontal examination by a single periodontist. Patients' reported outcomes will be evaluated on a visual analog scale (VAS) in terms of their satisfaction and any discomfort experienced.
Statistical analysis- Data will be collected and analysed at the end of study on excel sheets. Data recorded will be processed by standard statistical analysis. All statistical analysis will be carried out using statistical software (SPSS, Version 25.0 for Windows, SPSS, Chicago, IL). The normality of distribution of data will be examined by Shapiro Wilk test. Statistical analysis will be performed according to distribution of data. Test for homogeneity of variance will also be done to select statistics. If non normal distribution, Friedman test will be applied for intra group comparison and Mann Whitney test for intergroup comparison. If data will follow normal distribution, t-tests will be used for intergroup comparison and Repeated measures ANOVA for different time points. Statistical significance level will be set at p≤0.005.
- Conditions
- Periodontitis, Subgingival Plaque
- Being tested
- Conventional Subgingival Instrumentation, minimally invasive non-surgical periodontal therapy
- Medical subject headings
- Periodontitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Conventional Subgingival InstrumentationProcedure or surgery
On the conventional non-surgical periodontal therapy side, a power-driven piezo-electric ultrasonic scaling device with scaling tips will be used the majority of the time to debride subgingival biofilm and calculus, and manual standard Gracey curette instruments (Gracey curettes Hu-Friedy, Chicago, IL, USA) will be used to remove residual deposits from the root surface.
minimally invasive non-surgical periodontal therapyProcedure or surgery
minimally invasive non-surgical periodontal therapy will undergo careful scaling and root planing under magnification (use of 3.5 X magnification loupes) with mini curettes and using an ultrasonic device with specific thin and delicate tips. These instruments will be carefully inserted through the periodontal pocket of the affected tooth to reach the root surface for debridement. Caution will be taken to preserve the stability of soft tissues.
| Study group | Role | What they receive |
|---|---|---|
| Control group | Active comparator | On the conventional non-surgical periodontal therapy side, a power-driven piezo-electric ultrasonic scaling device with scaling tips will be used the majority of the time to debride subgingival biofilm and calculus, and manual standard Gracey curette instruments (Gracey curettes Hu-Friedy, Chicago, IL, USA) will be used to remove residual deposits from the root surface. Receives: Procedure: Conventional Subgingival Instrumentation |
| Test Group | Active comparator | Experimental sites designated to receive minimally invasive non-surgical periodontal therapy will undergo careful scaling and root planing under magnification (use of 3.5 X magnification loupes) with mini curettes and using an ultrasonic device with specific thin and delicate tips. These instruments will be carefully inserted through the periodontal pocket of the affected tooth to reach the root surface for debridement. Caution will be taken to preserve the stability of soft tissues. Receives: Procedure: minimally invasive non-surgical periodontal therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of diseased sites
Difference in No of Sites with PPD (probing pocket depth) > 4 mm and BOP (bleeding upon probing)
Measured: 6 weeks and 3 months
Secondary outcomes (3)
PROBING POCKET DEPTH(PPD)
It will be measured as the distance from the gingival margin to the base of the pocket using the calibrated manual periodontal probe (PCP-UNC 15 Hu-Friedy, Chicago, IL, USA). The probe will be inserted with a firm, gentle pressure to the bottom of the pocket and maintained parallel to the vertical axis of the tooth. Measurements will be noted at 6 sites of the involved teeth- mesiobuccal, midbuccal, distobuccal, mesiolingual, distolingual and midlingual.
Measured: 6 WEEKS AND 3 MONTHS
CLINICAL ATTACHMENT LEVEL(CAL)
It will be measured from cemento-enamel junction to base of the pocket. Measurements will be made at 6 sites of the involved tooth- mesiobuccal, midbuccal, distobuccal, mesiolingual, distolingual and midlingual. The mean clinical attachment loss over all examined surfaces will be calculated.
Measured: 6 WEEKS AND 3 MONTHS
GINGIVAL RECESSION(REC)
Gingival recession was measured as the distance from the Cementoenamel junction(CEJ) to the gingival margin (GM), parallel to the long axis of the tooth starting from the most apical point of recession.
Measured: 6 WEEKS AND 3 MONTHS
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 May 2023
- Study start10 Jul 2023 (estimated)
- Primary completion10 Oct 2023 (estimated)
- Study completion10 Nov 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PeriodontitisStudies of the same condition, open and under way.
- More trials run by Postgraduate Institute of Dental Sciences RohtakThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 20 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Postgraduate Institute of Dental Sciences Rohtak
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Ritika Arora, MDS, Principal investigator, PGIDS,ROHTAK
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05876455
- Sponsor's protocol ID
- RitikaArora23
- Status last verified
- May 2023
- First submitted
- 5 May 2023
- Last updated
- 25 May 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 May 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparative Evaluation of Minimally Invasive Nonsurgical Periodontal Therapy Versus Conventional Subgingival Instrumentation in Patients With Generalized Stage 2 and 3 Periodontitis - A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT05876455
- Acronym / sponsor ID
- RitikaArora23
- Conditions
- Periodontitis, Subgingival Plaque
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 20 participants (estimated)
- Lead sponsor
- Postgraduate Institute of Dental Sciences RohtakUniversity, hospital or other
- Study start
- 10 Jul 2023 (estimated)
- Primary completion
- 10 Oct 2023 (estimated)
- Study completion
- 10 Nov 2023 (estimated)
- First posted
- 25 May 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background- The use of minimally invasive procedures has recently been advocated for the treatment of periodontitis, to minimize patient discomfort and maximize the healing potential. These techniques usually involve the use of magnification lenses or microscopes and small instruments which reduce the risk of tissue trauma compared with traditional instruments.
Rationale- So far only descriptive data about the clinical effects of such procedure are available and comparative studies that would include other treatment alternatives are lacking. Therefore, the aim of this study is, on split-mouth model, to compare the number of diseased sites (defined by probing depth ˃ 4 mm and bleeding on probing) after conventional subgingival instrumentation and Minimally invasive nonsurgical periodontal therapy (MINST) with the usage of special mini instruments and magnifying loupes.
Objectives- To compare sites that have residual probing depth and require further surgical intervention after undergoing the two treatment modalities.
Methods- In this split mouth randomized controlled trial, Test group will undergo non surgical therapy under magnification and using special mini bladed instruments while the control group will undergo conventional subgingival instrumentation. Reevaluation will be at 6 weeks and 3 months.
Expected outcomes- If both the groups differ in outcomes after therapy, MINST can be used to minimize the number of sites that require surgery and hence will reduce treatment costs and morbidity.
Detailed description
Aim and objectives- The aim of this study is to evaluate the clinical outcomes after minimally invasive nonsurgical periodontal therapy versus after conventional scaling and root planing in stage 2 and stage 3 generalised periodontitis patients.
Primary Objective- 1. Comparative evaluation of number of sites with residual pocket depth > 4 mm and bleeding on pocket probing after MINST versus conventional SI at the end of 6 weeks and 3 months Secondary objective-
- Comparative evaluation of periodontal parameters viz. probing depth, clinical attachment level, gingival recession, treatment time and patient reported outcomes after MINST versus conventional SI at the end of 6 weeks and 3 months.
Methodology- Study design- This randomized controlled trial will be conducted in the department of Periodontics, Post graduate institute of dental sciences (PGIDS), Rohtak in accordance with the ethical standards outlined in the declaration of Helsinki 1975, as revised in 2013.The study design was approved by Institutional review board, PGIDS, Rohtak and ethical acceptance applied for from the Ethical committee of PGIDS, Rohtak. Patients coming to the out patient department of Periodontics, after examination, will be included in the study if they meet the following inclusion criteria.
Randomisation- It is a split mouth study so 2 quadrants within the same arch (intra arch) in each patient will be randomly allocated to test group and control group. For the randomization process, a computer-generated list will be used to define side and treatment modality.
Participants belonging to both the groups will receive oral hygiene instructions including toothbrushing, interdental cleaning, and plaque control reinforcement at every visit.
Test group- Experimental sites designated to receive minimally invasive non-surgical periodontal therapy will undergo careful scaling and root planing under magnification (use of 3.5 X magnification loupes) with mini curettes and using an ultrasonic device with specific thin and delicate tips. These instruments will be carefully inserted through the periodontal pocket of the affected tooth to reach the root surface for debridement. Caution will be taken to preserve the stability of soft tissues.
Control group- On the conventional non-surgical periodontal therapy side, a power-driven piezo-electric ultrasonic scaling device with scaling tips will be used the majority of the time to debride subgingival biofilm and calculus, and manual standard Gracey curette instruments (Gracey curettes Hu-Friedy, Chicago, IL, USA) will be used to remove residual deposits from the root surface.
Both procedures will be performed under local anesthesia and by a single experienced periodontist. All patients will be recalled after 6 weeks and 3 months after treatment for re-evaluation and professional supra-gingival plaque control.
Primary Outcome Measures:
Number of diseased sites [ Time Frame: 6 weeks, 3 months] Difference in No of Sites with PPD (probing pocket depth) > 4 mm and BOP (bleeding upon probing)
Secondary Outcome Measures:
PPD [ [ Time Frame: 6 weeks, 3 months] Average probing pocket depth CAL [ Time Frame: 6 weeks, 3 months] Clinical attachment level REC [ Time Frame: 6 weeks, 3 months] Gingival recession Sample size-: Sample size was calculated using G power statistical software. Using probing depth reduction as the outcome to determine effect size (as determined from a previous study- Ribeiro, F.V.; Casarin, R.C.; Palma, M.A.; Junior, F.H.; Sallum, E.A.; Casati, M.Z. Clinical and patient-centered outcomes after minimally invasive non-surgical or surgical approaches for the treatment of intrabony defects: A randomized clinical trial.J. Periodontol. 2011, 82, 1256-1266), a power of 80% and error of 5%, a sample size of 18 patients was calculated. Taking into account 10% attrition rate a total of 20 patients and a total of 40 quadrants will be recruited for this split mouth study.
Data collection and statistical analysis plan- Periodontal parameters will include plaque index, periodontal probing depth (PD): the distance from the free gingival margin to the bottom of gingival sulcus, gingival recession depth (REC), clinical attachment level (CAL), bleeding on pocket probing (BOP): recorded as bleeding site 30s after probing base of sulcus. These will be assessed at six sites per tooth at baseline, 6 weeks after treatment and 3 months after treatment.
The number of sites requiring surgical intervention will be noted at the last follow up at 3 months and compared between test and control groups. The time taken for both treatment types will also be noted.
The periodontal probe (UNC-15, Hu-Friedy, Chicago, IL, USA) will be used for periodontal examination by a single periodontist. Patients' reported outcomes will be evaluated on a visual analog scale (VAS) in terms of their satisfaction and any discomfort experienced.
Statistical analysis- Data will be collected and analysed at the end of study on excel sheets. Data recorded will be processed by standard statistical analysis. All statistical analysis will be carried out using statistical software (SPSS, Version 25.0 for Windows, SPSS, Chicago, IL). The normality of distribution of data will be examined by Shapiro Wilk test. Statistical analysis will be performed according to distribution of data. Test for homogeneity of variance will also be done to select statistics. If non normal distribution, Friedman test will be applied for intra group comparison and Mann Whitney test for intergroup comparison. If data will follow normal distribution, t-tests will be used for intergroup comparison and Repeated measures ANOVA for different time points. Statistical significance level will be set at p≤0.005.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Control group | Active comparator | Procedure: Conventional Subgingival InstrumentationOn the conventional non-surgical periodontal therapy side, a power-driven piezo-electric ultrasonic scaling device with scaling tips will be used the majority of the time to debride subgingival biofilm and calculus, and manual standard Gracey curette instruments (Gracey curettes Hu-Friedy, Chicago, IL, USA) will be used to remove residual deposits from the root surface. |
| Test Group | Active comparator | Procedure: minimally invasive non-surgical periodontal therapyExperimental sites designated to receive minimally invasive non-surgical periodontal therapy will undergo careful scaling and root planing under magnification (use of 3.5 X magnification loupes) with mini curettes and using an ultrasonic device with specific thin and delicate tips. These instruments will be carefully inserted through the periodontal pocket of the affected tooth to reach the root surface for debridement. Caution will be taken to preserve the stability of soft tissues. |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (2 listed)
- Systemically healthy patients having generalised Stage 2 or stage 3 periodontitis according to the American Academy of Periodontology (AAP) and the European Federation of Periodontology (EFP) periodontal classification
- A full-mouth plaque score (FMPS) and full-mouth bleeding score (FMBS) <20%, at least 5 teeth in each quadrant.
Key exclusion criteria (6 listed)
- pregnant or lactating
- requiring antibiotic premedication
- received antibiotic treatment in the previous 3 months
- received a course of periodontal treatment within the past 6 months
- smokers
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Conventional Subgingival InstrumentationOn the conventional non-surgical periodontal therapy side, a power-driven piezo-electric ultrasonic scaling device with scaling tips will be used the majority of the time to debride subgingival biofilm and calculus, and manual standard Gracey curette instruments (Gracey curettes Hu-Friedy, Chicago, IL, USA) will be used to remove residual deposits from the root surface. | Procedure or surgery | Control group |
| minimally invasive non-surgical periodontal therapyminimally invasive non-surgical periodontal therapy will undergo careful scaling and root planing under magnification (use of 3.5 X magnification loupes) with mini curettes and using an ultrasonic device with specific thin and delicate tips. These instruments will be carefully inserted through the periodontal pocket of the affected tooth to reach the root surface for debridement. Caution will be taken to preserve the stability of soft tissues. | Procedure or surgery | Test Group |
Primary outcome
Number of diseased sites
Time frame: 6 weeks and 3 months
Difference in No of Sites with PPD (probing pocket depth) > 4 mm and BOP (bleeding upon probing)
3 secondary outcomes
PROBING POCKET DEPTH(PPD)
Time frame: 6 WEEKS AND 3 MONTHS
CLINICAL ATTACHMENT LEVEL(CAL)
Time frame: 6 WEEKS AND 3 MONTHS
GINGIVAL RECESSION(REC)
Time frame: 6 WEEKS AND 3 MONTHS
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 May 2023.
Related trials for Periodontitis
Recruiting
Effect of Cryotherapeutic and Nanotherapeutic Sodium Hypochlorite on Post-Operative Endodontic Pain.
Symptomatic Irreversible Pulpitis, Symptomatic Apical Periodontitis
Active, not recruitingObservational study
A Retrospective Comparative Evaluation of Omega-3 and Resveratrol Supplementation in Patients With Periodontitis
Periodontitis
Recruiting
Probiotics Versus Antibiotics as an Adjuvant to Non-surgical Periodontal Treatment Among Smokers With Stage II, Grade B Periodontitis
Probiotics, Antibiotics
Recruiting
Effects of Different Activation Techniques on Antimicrobial Photodynamic Therapy in Apical Periodontitis
Apical Periodontitis, Endodontic Retreatment
Recruiting
Ozone Gel Versus Chlorohexidine Gel as an Adjunct to Non-Surgical Treatment of Stage II Periodontitis Grade B Among Smokers Patients
Ozone Gel, Chlorohexidine Gel
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ritika Arora, MDS principal investigator
PGIDS,ROHTAK
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Conventional Subgingival Instrumentation and minimally invasive non-surgical periodontal therapy in people with Periodontitis and Subgingival Plaque, run by Postgraduate Institute of Dental Sciences Rohtak at 1 site in India.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 25 May 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Ritika Arora, MDS (9810734445, drritika44@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of diseased sites (time frame: 6 weeks and 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 May 2023.